Butterfly Network (BFLY) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
29 Oct, 2026Executive summary
Q3 revenue rose 51.7% YoY to $32.6M, exceeding the high end of revenue and Adjusted EBITDA guidance; gross margin reached 73.0%.
Embedded partnerships, U.S. probe sales and enterprise momentum supported growth; FY26 revenue and Adjusted EBITDA guidance increased.
Financial highlights
Q3 revenue was $32.6M versus $21.5M YoY; nine-month revenue was $91.7M versus $66.1M.
Q3 gross profit was $23.8M versus a $3.8M loss; excluding the prior-year $17.5M inventory write-down, gross profit increased $10.1M, or 74% YoY.
Net loss narrowed to $12.8M, or $0.05 per share, from $34.0M, or $0.13 per share; nine-month net loss was $38.4M.
Adjusted EBITDA loss improved 85% to $1.2M from $8.1M; quarterly cash use was $2.4M versus $3.9M.
Q3 operating expenses were $37.4M, up 19% YoY; nine-month operating expenses were $106.5M versus $94.2M.
Outlook and guidance
FY26 revenue guidance increased to $123M–$126M, implying 26%–29% growth; Q4 revenue guidance is $31M–$34M.
FY26 Adjusted EBITDA loss guidance improved to $12M–$15M; Q4 loss guidance is $3M–$6M.
Home & Community Care scanning is set to begin in November, with initial revenue expected in Q4; revenue is expected to grow through 2027 and could become meaningful in 2028.
Management remains on track for Adjusted EBITDA and cash flow positivity in 2028; existing cash and operating cash flows are expected to fund operations for at least 12 months.
Latest events from Butterfly Network
- AI-enabled POCUS and chip licensing broaden growth beyond handheld ultrasound.BFLY
UBS Global Healthcare Conference - Platform strategy and key partnerships drive expansion into new markets and recurring revenue growth.BFLY
Morgan Stanley 24th Annual Global Healthcare Conference - Q2 2026 revenue up 39.5% to $32.6M, gross margin 71.4%, and Embedded partnerships drove growth.BFLY
Q2 2026 - Directors elected, auditor ratified, and executive compensation approved with no stockholder questions.BFLY
AGM 2026 - Semiconductor ultrasound tech, AI ecosystem, and licensing drive growth and industry expansion.BFLY
46th Annual William Blair Growth Stock Conference - AI-powered ultrasound and embedded tech drive global growth and financial improvement.BFLY
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue up 25%, gross margin at 68.9%, and adjusted EBITDA loss narrowed to $6.1M.BFLY
Q1 2026 - Proxy covers director elections, auditor ratification, and executive pay, with founder holding voting control.BFLY
Proxy filing - Votes include director elections, auditor ratification, and executive pay approval.BFLY
Proxy filing